Cargando…
Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy.
Autores principales: | Shapiro, Roman M., Romee, Rizwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861944/ https://www.ncbi.nlm.nih.gov/pubmed/35243428 http://dx.doi.org/10.1016/j.xcrm.2022.100537 |
Ejemplares similares
-
CAR NK Cell Therapy for T Follicular Helper Cells
por: King, Cecile
Publicado: (2020) -
Platelets Give a Running Start to Adult Hippocampal Neurogenesis
por: Schroer, Adam B., et al.
Publicado: (2019) -
Expanding the genetic landscape of obesity
por: Yang, Jian
Publicado: (2023) -
Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment
por: Lischer, Christopher, et al.
Publicado: (2023) -
Predicting in vivo activity of combination therapies from in vitro drug pairs in diverse environments
por: Patterson, Sarah, et al.
Publicado: (2022)